AVMA news
Blood-derived products demystified for equine practitioners
The American Association of Equine Practitioners’ Infectious Disease Committee recently updated the association’s white paper on equine blood, plasma,…
policy
Regenerative medicine, including therapeutic use of stem cells
Regenerative medicine holds promise in treating a variety of diseases, yet questions remain. The AVMA supports the continued scientific development of…
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
JAVMA news
In Short
Specialties proposed, ranitidine drugs contaminated, national disease list drafted
AVMA news
FDA approves anemia drug for cats with chronic kidney disease
Varenzin-CA1 from Elanco is the first drug for the control of nonregenerative anemia associated with chronic kidney disease in cats to receive…
AVMA news
AAFP, EveryCat release guidelines on diagnosis of feline infectious peritonitis
Feline infectious peritonitis is one of the most important infectious diseases and causes of death in cats, but the disease can be challenging to…
AVMA news
VMX 2023 draws a crowd for 40th anniversary
Several new studies were unveiled at @the_NAVC Veterinary Meeting & Expo this January in Orlando, Florida, including research identifying 30 different…